Clinical Trials Browser

Phase 4 × Lymphoma, Extranodal NK-T-Cell × Etoposide × Clear all

NCT04999878 2021-08-11

RUE-DDGP

Phase 4 Unknown

LymphoidMyeloid

Lymphohistiocytosis, Hemophagocytic, Lymphoma, Extranodal NK-T-Cell

NCT04038411 2019-07-30

PD-1 Antibody, Chidamide, Lenalidomide and Etoposide for Relapsed or Refractory NK/T Cell Lymphoma

Phase 4 Unknown

Lymphoma, Extranodal NK-T-Cell